Autopsy report · NCT04130438

Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging

“Low recruitment, insufficient funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 6 months before it started.
• Ran for about 4 years before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Myocardial Bridging

Interventions

Nebivolol; Diltiazem; Placebo

Participants

5

Sites

1

Countries

United States

Trials that died the same way

• Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
  “insufficient funding and recruitment” (96% match in meaning)
• Probiotic Lactobacillus GG to Eliminate VRE Colonization
  “Insufficient recruitment, no additional funding available” (92% match in meaning)
• Reach Out and Read Arabic to Promote Arabic Literacy in Toddlers
  “Poor recruitment and lack of funding” (88% match in meaning)
• Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression
  “Difficulty in recruitment and funding.” (84% match in meaning)
• Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
  “Low recruitment, completion of funding cycle” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.